GlassScriptPhysician profile
Tracy E Mcintyre
NPI 1013204486
$5,017.54
in general payments reported to CMS, 2019-2025
31 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what 89% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $364 · 2022: $1,029 · 2023: $913 · 2024: $1,385 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,625.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $592.45 | 2021-2025 | Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $526.55 | 2021-2025 | Jardiance |
| Amgen INC. | $460.82 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $443.04 | 2022-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $380.70 | 2022-2025 | Watchman Flx, Watchman |
| Abbott Laboratories | $315.65 | 2021-2023 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $300.18 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $247.57 | 2021-2025 | Verquvo, Capvaxive |
| Alnylam Pharmaceuticals INC. | $179.59 | 2024-2025 | Onpattro |
| Bridgebio Pharma, INC. | $177.60 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $175.90 | 2024 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $156.34 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $155.28 | 2023-2024 | |
| Baxter Healthcare | $133.33 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
| Pfizer INC. | $113.02 | 2021-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $108.23 | 2023-2024 | Xarelto |
| Philips North America LLC | $88.58 | 2023-2024 | (Ck7) Extended Holter, (Ck4) Mcot |
| Cvrx, INC. | $84.92 | 2022 | |
| W. L. Gore & Associates, INC. | $58.95 | 2022 | |
| Amarin Pharma, INC. | $56.82 | 2022-2023 | |
| Heartflow, INC. | $44.83 | 2023-2024 | Ffrct |
| Bayer Healthcare Pharmaceuticals INC. | $37.78 | 2025 | |
| Esperion Therapeutics, INC. | $29.10 | 2022-2025 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $28.78 | 2023 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.32 | 2021 | |
| Lilly USA, LLC | $20.34 | 2025 | Zepbound |
| Impulse Dynamics (USA) INC. | $17.07 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $17.00 | 2022 | |
| Irhythm Technologies, INC. | $15.82 | 2022 | |
| Abiomed | $14.94 | 2025 | |
| Kestra Medical Technology Services, INC. | $14.04 | 2024 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Mcintyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.